Crossmark

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ

Crossref DOI link: https://doi.org/10.1186/s12969-018-0278-1

Published: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lei, Linda http://orcid.org/0000-0003-3734-3173
Muhammad, Sabina

Al-Obaidi, Muthana

Sebire, Neil

Cheng, Iek Leng

Eleftheriou, Despina

Brogan, Paul
License Information

Text and Data Mining valid from 2018-09-26
More Information

Article History

Received: 19 March 2018

Accepted: 18 September 2018

First Online: 26 September 2018

Ethics approval and consent to participate

: This study was performed with ethical approval and consent from all included in the study.

: Written informed consent for publication was obtained from all included in the study.

: DE has institutional grants from Pfizer and Lilly. PB received consultancy fees from Roche and SOBI, institutional grants from Roche, SOBI and Novartis, and speaker fees from UCB. The other authors have declared no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.